# reload+after+2024-01-20 14:44:20.243643
address1§3655 Nobel Drive
address2§Suite 260
city§San Diego
state§CA
zip§92122
country§United States
phone§858 926 7655
website§https://www.darebioscience.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder; and DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy. The company's Phase I-ready products are DARE-VVA1, a proprietary formulation of tamoxifen for intravaginal to treat vulvar vaginal atrophy in women with hormone-receptor positive breast cancer; DARE-PDM1, a proprietary hydrogel formulation of diclofenac, a nonsteroidal anti-inflammatory drug, for vaginal administration as a treatment for dysmenorrhea; DARE-204 and DARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-GML, an intravaginally-delivered potential multi-target antimicrobial agent formulated with glycerol monolaurate; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; and DARE-RH1, a non-hormonal contraception for men and women. The company entered into license agreement with Organon & Co. and Organon International GmbH to commercialize XACIATO. Daré Bioscience, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
fullTimeEmployees§25
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Sabrina Martucci Johnson', 'age': 56, 'title': 'President, CEO, Secretary & Director', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 804068, 'exercisedValue': 0, 'unexercisedValue': 13557}, {'maxAge': 1, 'name': 'Ms. Lisa  Walters-Hoffert', 'age': 64, 'title': 'Chief Financial Officer', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 523200, 'exercisedValue': 0, 'unexercisedValue': 5214}, {'maxAge': 1, 'name': 'Mr. John A. Fair', 'age': 52, 'title': 'Chief Commercial Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 519405, 'exercisedValue': 0, 'unexercisedValue': 5214}, {'maxAge': 1, 'name': 'Mr. Mark  Walters', 'age': 68, 'title': 'Vice President of Operations', 'yearBorn': 1955, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. MarDee J. Haring-Layton', 'age': 47, 'title': 'Vice President of Accounting & Finance', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. David  Friend', 'title': 'Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.06
priceToSalesTrailing12Months§35.482433
currency§USD
dateShortInterest§1702598400
forwardEps§-0.21
exchange§NCM
quoteType§EQUITY
shortName§Dare Bioscience, Inc.
longName§Daré Bioscience, Inc.
firstTradeDateEpochUtc§1397136600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§79b82021-a19d-3c2b-be19-b7a9d44205d1
gmtOffSetMilliseconds§-18000000
targetHighPrice§6.0
targetLowPrice§2.0
targetMeanPrice§4.0
targetMedianPrice§4.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§5
quickRatio§0.57
grossMargins§0.9
ebitdaMargins§0.0
trailingPegRatio§None
